These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 34872558)

  • 21. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015.
    Pradipta IS; Van't Boveneind-Vrubleuskaya N; Akkerman OW; Alffenaar JC; Hak E
    Antimicrob Resist Infect Control; 2019; 8():115. PubMed ID: 31338162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
    Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
    JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence and risk factors on the resistance related to second-line drugs among multi-drug resistant tuberculosis cases in Shanghai, China].
    Li J; Zhang YY; Gui XH; Yuan ZA; Pan QC; Mei J; Shen X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Aug; 33(8):796-8. PubMed ID: 22967331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013.
    Xia H; Zheng Y; Liu D; Wang S; He W; Zhao B; Song Y; Ou X; Zhou Y; van den Hof S; Cobelens F; Zhao Y
    Microbiol Spectr; 2021 Dec; 9(3):e0040921. PubMed ID: 34851179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistant tuberculosis in Saudi Arabia: an analysis of surveillance data 2014-2015.
    Al Ammari M; Al Turaiki A; Al Essa M; Kashkary AM; Eltigani SA; Ahmed AE
    Antimicrob Resist Infect Control; 2018; 7():12. PubMed ID: 29387346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary and secondary anti-tuberculosis drug resistance in Hitossa District of Arsi Zone, Oromia Regional State, Central Ethiopia.
    Hamusse SD; Teshome D; Hussen MS; Demissie M; Lindtjørn B
    BMC Public Health; 2016 Jul; 16():593. PubMed ID: 27430266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.
    Hu Y; Hoffner S; Jiang W; Wang W; Xu B
    BMC Infect Dis; 2010 Feb; 10():43. PubMed ID: 20187977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving rifampicin and isoniazid mono-resistance in a high multidrug-resistant and extensively drug-resistant tuberculosis region: a retrospective data analysis.
    Mvelase NR; Balakrishna Y; Lutchminarain K; Mlisana K
    BMJ Open; 2019 Nov; 9(11):e031663. PubMed ID: 31699736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
    Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of drug-resistant tuberculosis in New Jersey from 1991 to 1995.
    Liu Z; Shilkret KL; Finelli L
    Int J Epidemiol; 1998 Feb; 27(1):121-6. PubMed ID: 9563705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017.
    Okethwangu D; Birungi D; Biribawa C; Kwesiga B; Turyahabwe S; Ario AR; Zhu BP
    BMC Infect Dis; 2019 May; 19(1):387. PubMed ID: 31064332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing prevalence and resistance patterns in children with drug-resistant tuberculosis in Mumbai.
    Shah I; Shah F
    Paediatr Int Child Health; 2017 May; 37(2):135-138. PubMed ID: 27686119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tuberculosis drug resistance pattern among pulmonary tuberculosis patients with or without HIV infection in Mwanza, Tanzania.
    Range N; Friis H; Mfaume S; Magnussen P; Chanualucha J; Kilale A; Mugomela A; Andersen AB
    Tanzan J Health Res; 2012 Oct; 14(4):243-9. PubMed ID: 26591721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015-2018: A retrospective study.
    Xu Y; Li Q; Zhu M; Wu X; Wang D; Luo J; Li Y; Zhong J; Zeng P
    Medicine (Baltimore); 2020 Oct; 99(43):e22608. PubMed ID: 33120748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug Resistance Characteristics of
    Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
    Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
    [No Abstract]   [Full Text] [Related]  

  • 40. Rates and risk factors for drug resistance tuberculosis in Northeastern China.
    Liu Q; Zhu L; Shao Y; Song H; Li G; Zhou Y; Shi J; Zhong C; Chen C; Lu W
    BMC Public Health; 2013 Dec; 13():1171. PubMed ID: 24330553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.